National Health Investors INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
National Health Investors, Inc. reported strong 2025 performance, exceeding guidance with significant growth in Normalized FFO and FAD, and announced its 2026 Annual Meeting of Stockholders.
NYSE
National Health Investors (NHI) is urging shareholders to vote for its director nominees, disagreeing with a recommendation from Institutional Shareholder Services (ISS) that NHI believes would jeopardize the company's superior shareholder returns.
NYSE
DEFA14A: Egan-Jones Recommends National Health Investors Stockholders Vote FOR All Director Nominees
Leading proxy advisory firm Egan-Jones recommends National Health Investors (NHI) stockholders vote for all of NHI's director nominees at the upcoming Annual Meeting.
NYSE
National Health Investors, Inc. has filed a definitive proxy statement with the SEC.
NYSE
DEFA14A: National Health Investors Urges Stockholders to Vote for Board Nominees Amidst Proxy Contest
National Health Investors (NHI) is urging stockholders to vote for its board nominees at the upcoming annual meeting, highlighting superior shareholder returns and a refreshed board.
NYSE
DEFC14A: Land & Buildings Seeks Boardroom Change at National Health Investors, Citing Governance Concerns
Land & Buildings is soliciting proxies to elect its two nominees to the board of National Health Investors, aiming to address what it perceives as archaic corporate governance and conflicts of interest.
NYSE
DEFA14A: National Health Investors Urges Stockholders to Vote FOR Nominees Amidst Activist Challenge
National Health Investors files definitive proxy materials and urges stockholders to vote for its director nominees at the upcoming Annual Meeting on May 21, 2025, amidst a challenge from activist hedge fund Land & Buildings.
NYSE
National Health Investors reports a return to growth in 2024, outperforming the Nareit Healthcare REIT Index, while simultaneously navigating a proxy contest initiated by Land & Buildings.
NYSE
National Health Investors (NHI) has appointed Robert W. Chapin, Jr. to its Board of Directors, effective immediately, to enhance expertise in senior housing and real estate investments.
NYSE
National Health Investors (NHI) is supplementing its proxy statement to address stockholder concerns raised by Land & Buildings Capital Management, including committing to declassifying the board and searching for a new independent director.
NYSE
National Health Investors, Inc. files its definitive proxy statement with the SEC.
NYSE
National Health Investors (NHI) is focusing on reigniting growth through organic and external initiatives after transitioning through a portfolio optimization phase.